Scientific Editors: George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan)
Commenting Expert: Emiel Rutgers, Netherlands Cancer Institute, Amsterdam
In this edition:
1. Lapatinib: Targets Breast Cancer Stem Cells?
Angel Rodriguez, Baylor College, Houston…
 Lorie Hughes |  Rachel Ellsworth |  Rowan Chlebowski |  Victor Vogel |
REFERENCE: Abstract: 29
LORIE HUGHES, The Hope Center, Cartersville GA
The intergroup study E-5194 has found that local excision without radiation
 Rachel Johnson |  Terry Mamounas |  William Gradishar |
REFERENCE: Abstract: 2090
RACHEL JOHNSON, Christie Hospital, Manchester
Some patients with HER-2 positive early breast cancer fare better if trastuzumab is withheld, according to
 Joan Houghton |  Elizabeth Barrett-Connor |  Fran Balkwill |  Carl Christophe Schimanski |
 Robert Ozols |  Lawrence Wickerham |  Patricia Ganz |  Jorma Paavonen |  Noah Kauff |
Robert Ozols of the Fox Chase Cancer Center in Philadelphia joins Derek Thorne to talk about the top presentations on cancer prevention.
– Raloxifene is as good as tamoxifen at
 Julie Gralow |  Charles Geyer |  Judith Bliss |  Robert Coleman |
Julie Gralow, from the Fred Hutchinson Cancer Research Center in Seattle, joins Derek Thorne to talk about the latest news from the ASCO annual meeting in Atlanta.
– In women with
